News & Events
June 30, 2022
Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical TrialsWhen: Thursday, June 30, 10 a.m. – 12 p.m. ET C-Path’s Transplant Therapeutics Consortium (TTC) invites you to join its upcoming webinar, Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical Trials. TTC, in collaboration with key opinion leaders from academic institutions, the pharmaceutical industry, health authorities and the patient community, is hosting this event for stakeholders to come......
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel BiomarkersTitle Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development......
September 27, 2018 - September 28, 2018
Workshop on Evidence-Based Treatment Decisions in Transplantation Informs PRO and Patient-Focused Drug DevelopmentThe U.S. Food and Drug Administration (FDA) held a public workshop on September 27-28, 2018 at its White Oak Campus in Silver Spring, MD. titled “Evidence-Based Treatment Decisions in Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment.” The workshop was planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC),......